期刊文献+

补肾调脂汤治疗高脂血症临床观察 被引量:3

Clinical observation on treating hyperlipemia with Bushentiaozhi Decoction
原文传递
导出
摘要 目的观察补肾调脂汤治疗肾虚血瘀型高脂血症的临床疗效和安全性及其与c-反应蛋白的关系。方法将符合诊断标准的原发性高脂血症患者60例随机分为治疗组(A)和脂必妥对照组(B),疗程6周,观察2组总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、C反应蛋白(CRP)的变化,及其2组血脂疗效的比较以及TC、TG与CRP的关系。结果6周后TC、TG、HDL-C、LDL-C、CRP A、B组治疗前后及2组间均有统计学差异。2组血脂控制疗效对比P<0.05,CRP与TC、TG存在正相关关系。结论用补肾调脂汤治疗肾虚血瘀型高脂血症有较好的临床效果,且安全性较高。 Objective To observe the clinical therapeutic effect of Bushengtiaozhi Decoction on hyperlipemia with renal deficiency and blood stasis and its security, and the relationship between curative effect and C-reactive protein. Method Sixty cases of patients with essential hyperlipidemia were randomly divided into treatment group and Zhibituo control group with 6 weeks of treatment. Changes of total cholesterol ( TC ), triglyeride ( TG ), high density lipoprotein-cholesterol ( HDL-C ), low density lipoprotein-cholesterol( LDL-C ) and C-reactive protein (CRP) were observed. The relationship between TC or TG and CRP was analyzed. Results There were significant differences in TC, TG , HDL-C, LDL- C and CRP between pretherapy and post-treatment, and between treatment group and control group. CRP was positively related with both TC and TG. Conclusion Bushengtiaozhi Decoction has better clinical therapeutic effect on hyperlipemia with renal deficiency and blood stasis and has higher security.
作者 郑爱军
出处 《北京中医药大学学报》 CAS CSCD 北大核心 2007年第9期646-648,共3页 Journal of Beijing University of Traditional Chinese Medicine
关键词 补肾调脂汤 高脂血症 C-反应蛋白 Bushentiaozhi Decoction hyperlipemia C-reactive protein
  • 相关文献

参考文献2

二级参考文献6

  • 1Roberts WL,Mouton L,Law TC,et al. Evluation of nine animated high sensitivity C-reactive protein methods:implications for clinical and epidemiological applications[J]. Clin Chem,2001,47(3) :418-423.
  • 2Ross R. Atherosclerosis-an inflammatory disease[J]. N Eng J med,1999,340:115-126.
  • 3Libby P, Ridker PM. Novel inflammatory markers of Coronary risk., theory versur practice[J]. Circulation, 1999, 100(8):1148-1150.
  • 4Paseri V, Cheng JS, Willerson JT, et al. Modulation of C-reactive protein mediated monocyte chemoattractant,protein-1 induction in human endothelial ceils by anti-atherosclerosis drugs[J]. Circulation,2001,103(21) :2531-2534.
  • 5Zwaka TP, Hombach V, Torzewski J. C - reactive protein-mediated low density lipoprotein uptake by macrophages:implications for atherosclerosis[J]. Circulation, 2001,103(9):1194-1197.
  • 6方圻,王钟林,宁田海,邵耕,陈在嘉,陆宗良,李健斋,林传骧,周北凡,诸骏仁,诸永康,陶萍,陶寿淇,龚兰生,顾复生,游凯,戴玉华.血脂异常防治建议[J].中华心血管病杂志,1997,25(3):169-175. 被引量:3067

共引文献195

同被引文献40

引证文献3

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部